Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Nuvalent Inc. Class A Common Stock (NASDAQ: NUVL)

 
NUVL Technical Analysis
5
As on 9th Jun 2023 NUVL STOCK Price closed @ 41.82 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 16.23 & Strong Buy for SHORT-TERM with Stoploss of 15.80 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

NUVLSTOCK Price

Open 42.68 Change Price %
High 42.92 1 Day -0.67 -1.58
Low 41.42 1 Week -0.28 -0.67
Close 41.82 1 Month 7.47 21.75
Volume 184321 1 Year 21.15 102.32
52 Week High 44.59 | 52 Week Low 7.40
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
NUVL
Daily Charts		 NUVL
Intraday Charts		 Whats New @
Bazaartrend		 NUVL
Free Analysis
 
NUVL Important Levels Intraday
RESISTANCE44.71
RESISTANCE43.78
RESISTANCE43.21
RESISTANCE42.64
SUPPORT41.00
SUPPORT40.43
SUPPORT39.86
SUPPORT38.93
 
NUVL Forecast April 2024
Share
4th UP Forecast58.06
3rd UP Forecast52.85
2nd UP Forecast49.63
1st UP Forecast46.41
1st DOWN Forecast37.23
2nd DOWN Forecast34.01
3rd DOWN Forecast30.79
4th DOWN Forecast25.58
 
NUVL Weekly Forecast
4th UP Forecast47.18
3rd UP Forecast45.46
2nd UP Forecast44.40
1st UP Forecast43.34
1st DOWN Forecast40.30
2nd DOWN Forecast39.24
3rd DOWN Forecast38.18
4th DOWN Forecast36.46
 
NUVL Forecast2024
4th UP Forecast115.18
3rd UP Forecast91.65
2nd UP Forecast77.11
1st UP Forecast62.57
1st DOWN Forecast21.07
2nd DOWN Forecast6.53
3rd DOWN Forecast-8.01
4th DOWN Forecast-31.54
 
 
NUVL Other Details
Segment EQ
Market Capital 1164610176.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
NUVL Address
NUVL
 
NUVL Latest News
 
Your Comments and Response on Nuvalent Inc. Class A Common Stock
 
NUVL Business Profile
Nuvalent, Inc., a preclinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor, designed to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and also remain active in the presence of mutations conferring resistance to approved and investigational ROS1 inhibitors; and NVL-655, a brain-penetrant ALK-selective inhibitor, designed to inhibit ALK fusions that express the normal ALK kinase domain without any drug-resistant mutations and also remain active in the presence of mutations conferring resistance to first, second, and third generation ALK inhibitors. The company was incorporated in 2017 and is headquartered in Cambridge, Massachusetts. Address: One Broadway, Cambridge, MA, United States, 02142
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service